93 related articles for article (PubMed ID: 12724012)
21. The potential mechanism of chemosensitive difference between 2 types of ovarian cancer.
He X; Lin B; Kong L; Zhang J
Saudi Med J; 2007 Jul; 28(7):1044-9. PubMed ID: 17603707
[TBL] [Abstract][Full Text] [Related]
22. Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients.
Rugge M; Fassan M; Clemente R; Rizzardi G; Giacomelli L; Pennelli G; Mescoli C; Segat D; Rea F
Clin Cancer Res; 2008 Jan; 14(1):149-54. PubMed ID: 18172265
[TBL] [Abstract][Full Text] [Related]
23. Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.
Manaios L; Tsiambas E; Alevizaki M; Karameris A; Alexopoulou D; Lambropoulou S; Moreas H; Kravvaritis C; Fotiades PP; Goula K; Patsouris E; Athanassiou AE; Koutras D; Katsilambros N
J BUON; 2008; 13(4):537-41. PubMed ID: 19145676
[TBL] [Abstract][Full Text] [Related]
24. Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.
Stawerski P; Wagrowska-Danilewicz M; Stasikowska O; Gottwald L; Danilewicz M
Pol J Pathol; 2008; 59(1):27-32. PubMed ID: 18655368
[TBL] [Abstract][Full Text] [Related]
25. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases.
Soga J
Cancer; 2005 Apr; 103(8):1587-95. PubMed ID: 15742328
[TBL] [Abstract][Full Text] [Related]
26. Carcinoids of the ovary: an analysis of 329 reported cases.
Soga J; Osaka M; Yakuwa Y
J Exp Clin Cancer Res; 2000 Sep; 19(3):271-80. PubMed ID: 11144518
[TBL] [Abstract][Full Text] [Related]
27. Primary pure insular ovarian carcinoids.
Holtz G; Tucker E; Holtz F
Obstet Gynecol; 1979 Mar; 53(3 Suppl):85S-87S. PubMed ID: 424138
[TBL] [Abstract][Full Text] [Related]
28. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
29. Expression of cyclooxygenase-2 and DNA topoisomerase II alpha in precancerous and cancerous lesions of the oral mucosa.
Segawa E; Sakurai K; Kishimoto H; Takaoka K; Noguchi K; Hashitani S; Hirota S; Urade M
Oral Oncol; 2008 Jul; 44(7):664-71. PubMed ID: 17996482
[TBL] [Abstract][Full Text] [Related]
30. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
Wong KK; Lu KH; Malpica A; Bodurka DC; Shvartsman HS; Schmandt RE; Thornton AD; Deavers MT; Silva EG; Gershenson DM
Int J Gynecol Pathol; 2007 Oct; 26(4):404-9. PubMed ID: 17885490
[TBL] [Abstract][Full Text] [Related]
31. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
[TBL] [Abstract][Full Text] [Related]
32. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
33. Primary ovarian carcinoid tumor with luteinized stromal cells.
Engohan-Aloghe C; Buxant F; Noël JC
Arch Gynecol Obstet; 2009 Jul; 280(1):119-21. PubMed ID: 19039598
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of cyclooxygenase-2 and DNA topoisomerase IIalpha expression in oral carcinoma.
Sakurai K; Urade M; Noguchi K; Hashitani S; Takaoka K; Segawa E; Kishimoto H
Head Neck; 2007 Nov; 29(11):1002-9. PubMed ID: 17427971
[TBL] [Abstract][Full Text] [Related]
35. Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer.
Goodell V; Salazar LG; Urban N; Drescher CW; Gray H; Swensen RE; McIntosh MW; Disis ML
J Clin Oncol; 2006 Feb; 24(5):762-8. PubMed ID: 16391298
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
37. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA
Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
[TBL] [Abstract][Full Text] [Related]
39. [Proliferative activity in pulmonary carcinoids].
Resl M; Bukac J; Simek J; Siller J; Rothröckel P
Cesk Patol; 2000 Jan; 36(1):32-4. PubMed ID: 10838756
[TBL] [Abstract][Full Text] [Related]
40. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
